Intracavitary cidofovir for human herpes virus-8-associated primary effusion lymphoma in an HIV-negative patient.
Stingaciu
Sorin
S
Onco-Hematology Department, l'Archet Hospital, 06000 Nice, France.
Ticchioni
Michel
M
Sudaka
Isabelle
I
Haudebourg
Juliette
J
Mounier
Nicolas
N
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000008:administration & dosage*; D000077404:Cidofovir; D003520:Cyclophosphamide / Q000627:therapeutic use; D003596:Cytosine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D006566:Herpesviridae Infections / Q000188:drug therapy*; D019288:Herpesvirus 8, Human / Q000302:isolation & purification; D006801:Humans; D007267:Injections; D054685:Lymphoma, Primary Effusion / Q000188:drug therapy* / Q000473:pathology / Q000821:virology; D063065:Organophosphonates / Q000008:administration & dosage*; D010996:Pleural Effusion / Q000209:etiology; D011241:Prednisone / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000998:Antiviral Agents; D063065:Organophosphonates; D014750:Vincristine; D004317:Doxorubicin; D003596:Cytosine; D003520:Cyclophosphamide; D000077404:Cidofovir; D011241:Prednisone